Tennessee Oncology PLLC — Nashville, Tennessee

Tennessee Oncology PLLC is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Tennessee Oncology PLLC has participated in 77 clinical trials with 14 currently active.

Therapeutic areas: Advanced Prostate Cancer, Solid Tumor, Non Small Cell Lung Cancer.

Sponsors: SCRI Development Innovations, LLC, Eli Lilly and Company, Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology PLLC?

Tennessee Oncology PLLC has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology PLLC conducted?

Tennessee Oncology PLLC has 77 clinical trials on record, with 14 currently active. Their work covers Advanced Prostate Cancer, Solid Tumor, Non Small Cell Lung Cancer.

Is Tennessee Oncology PLLC accredited by Crixeo Health?

Yes — Tennessee Oncology PLLC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Tennessee Oncology PLLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.